These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 12447698
41. Expression of a novel matrix metalloproteinase regulator, RECK, and its clinical significance in resected non-small cell lung cancer. Takenaka K, Ishikawa S, Kawano Y, Yanagihara K, Miyahara R, Otake Y, Morioka Y, Takahashi C, Noda M, Wada H, Tanaka F. Eur J Cancer; 2004 Jul; 40(10):1617-23. PubMed ID: 15196549 [Abstract] [Full Text] [Related]
42. The ß1-integrin-dependent function of RECK in physiologic and tumor angiogenesis. Miki T, Shamma A, Kitajima S, Takegami Y, Noda M, Nakashima Y, Watanabe K, Takahashi C. Mol Cancer Res; 2010 May; 8(5):665-76. PubMed ID: 20407016 [Abstract] [Full Text] [Related]
43. Inhibitory effects of a benz[f]indole-4,9-dione analog on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells. Park HJ, Lee HJ, Min HY, Chung HJ, Suh ME, Park-Choo HY, Kim C, Kim HJ, Seo EK, Lee SK. Eur J Pharmacol; 2005 Dec 19; 527(1-3):31-6. PubMed ID: 16309669 [Abstract] [Full Text] [Related]
45. VEGF expression and the effect of NSAIDs on ascites cell proliferation in the hen model of ovarian cancer. Urick ME, Giles JR, Johnson PA. Gynecol Oncol; 2008 Sep 19; 110(3):418-24. PubMed ID: 18606441 [Abstract] [Full Text] [Related]
46. RECK-mediated inhibition of glioma migration and invasion. Silveira Corrêa TC, Massaro RR, Brohem CA, Taboga SR, Lamers ML, Santos MF, Maria-Engler SS. J Cell Biochem; 2010 May 19; 110(1):52-61. PubMed ID: 20127710 [Abstract] [Full Text] [Related]
48. [Molecular mechanism of reversing metastatic phenotype in human high-metastatic large cell lung cancer cell line L9981 by nm23-H1]. Che GW, Zhou QH, Zhu W, Wang YP, Qin Y, Liu LX, Chen XH, Sun YL, Sun ZF. Ai Zheng; 2005 Mar 19; 24(3):278-84. PubMed ID: 15757527 [Abstract] [Full Text] [Related]
52. Effects of anti-inflammatory drugs on proliferation, cytotoxicity and osteogenesis in bone marrow mesenchymal stem cells. Chang JK, Li CJ, Wu SC, Yeh CH, Chen CH, Fu YC, Wang GJ, Ho ML. Biochem Pharmacol; 2007 Nov 01; 74(9):1371-82. PubMed ID: 17714695 [Abstract] [Full Text] [Related]
54. Depsipeptide a histone deacetlyase inhibitor down regulates levels of matrix metalloproteinases 2 and 9 mRNA and protein expressions in lung cancer cells (A549). Vinodhkumar R, Song YS, Ravikumar V, Ramakrishnan G, Devaki T. Chem Biol Interact; 2007 Feb 20; 165(3):220-9. PubMed ID: 17240363 [Abstract] [Full Text] [Related]
57. Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1. Ramer R, Hinz B. J Natl Cancer Inst; 2008 Jan 02; 100(1):59-69. PubMed ID: 18159069 [Abstract] [Full Text] [Related]
59. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells. Spinella F, Rosanò L, Di Castro V, Nicotra MR, Natali PG, Bagnato A. Clin Cancer Res; 2004 Jul 15; 10(14):4670-9. PubMed ID: 15269139 [Abstract] [Full Text] [Related]